Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

VEGFR2/CD309 anticorps (AA 1268-1341)

Cet anticorps anti-VEGFR2/CD309 est un anticorps Lapin Polyclonal détectant VEGFR2/CD309 dans ELISA et IHC (p). Adapté pour Humain, Souris et Rat.
N° du produit ABIN7227056
-15% Promotion 2026
530,08 €
623,62 €
Économisez 93,54 € (-15 %)
Plus frais de livraison 40,00 € et TVA
Destination: France
Envoi sous 10 à 14 jours ouvrables

Aperçu rapide pour VEGFR2/CD309 anticorps (AA 1268-1341) (ABIN7227056)

Antigène

Voir toutes VEGFR2/CD309 (VEGFR2) Anticorps
VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))

Reactivité

  • 340
  • 214
  • 142
  • 17
  • 9
  • 5
  • 3
  • 3
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Humain, Souris, Rat

Hôte

  • 296
  • 67
  • 42
  • 14
  • 1
  • 1
  • 1
Lapin

Clonalité

  • 277
  • 145
Polyclonal

Conjugué

  • 182
  • 34
  • 20
  • 16
  • 14
  • 10
  • 10
  • 8
  • 8
  • 8
  • 8
  • 7
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp VEGFR2/CD309 est non-conjugé

Application

  • 221
  • 120
  • 111
  • 111
  • 63
  • 35
  • 26
  • 25
  • 22
  • 15
  • 13
  • 13
  • 9
  • 7
  • 7
  • 6
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
  • Épitope

    • 39
    • 34
    • 26
    • 23
    • 21
    • 16
    • 16
    • 11
    • 11
    • 10
    • 9
    • 9
    • 6
    • 5
    • 5
    • 5
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1268-1341

    Fonction

    VEGFR2 Polyclonal Antibody

    Specificité

    The antibody detects endogenous VEGFR2.

    Purification

    The antibody was affinity-purified from rabbit serum by affinity-chromatography using specific immunogen

    Immunogène

    Synthetic peptide from human protein at AA range: 1268-1341

    Isotype

    IgG
  • Indications d'application

    Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: IHC-P (1:50-1:300), ELISA (1:5000-1:20000).

    Commentaires

    Primary Antibody

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1 mg/mL

    Buffer

    PBS, pH 7.4, containing 0.02 % Sodium Azide as preservative and 50 % Glycerol.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    -20 °C

    Stockage commentaire

    Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
  • Antigène

    VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))

    Autre désignation

    VEGFR2

    Sujet

    Rabbit Anti-VEGFR2 Polyclonal Antibody,Vascular endothelial growth factor receptor 2, VEGFR-2, Fetal liver kinase 1, FLK-1, Kinase insert domain receptor, KDR, Protein-tyrosine kinase receptor flk-1, CD antigen CD309,Vascular endothelial growth factor (VEGF) is a major growth factor for endothelial cells. KDR (kinase insert domain receptor) encodes one of the two receptors of the VEGF. This receptor, known as kinase insert domain receptor, is a type III receptor tyrosine kinase. It functions as the main mediator of VEGF-induced endothelial proliferation, survival, migration, tubular morphogenesis and sprouting. The signalling and trafficking of this receptor are regulated by multiple factors, including Rab GTPase, P2Y purine nucleotide receptor, integrin alphaVbeta3, T-cell protein tyrosine phosphatase, etc. Mutations of KDR are implicated in infantile capillary hemangiomas.,VEGFR2

    ID gène

    3791

    UniProt

    P35968

    Pathways

    Signalisation RTK, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
Vous êtes ici:
Chat with us!